Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background Ketamine has been reported to exert anti-inflammatory effects on macrophages stimulated with lipopolysaccharide (LPS) in vitro and in vivo. Several studies have reported conflicting results regarding the effects of propofol on cytokine production from immune cells. However, there have been no reports of the effects of these agents on inflammatory responses in glial cells. We investigated the effects of ketamine and propofol on LPS-induced production of nitric oxide, tumour necrosis factor-alpha (TNF-alpha) and prostaglandin E(2) (PGE(2)) from primary cultures of rat glial cells in vitro. Methods Glial cells were stimulated with LPS in the absence and presence of various concentrations of ketamine (30-1000 microM) or propofol (30 and 300 microM). Nitric oxide released into the culture media was determined by measuring nitrite using the Griess reaction, and concentrations of TNF-alpha and PGE(2) were measured by enzyme-linked immunosorbent assay (ELISA). Results Ketamine reduced LPS-induced TNF-alpha production without significant inhibition of nitrite release in mixed glial cells, astrocyte cultures and microglial cultures. Ketamine also inhibited LPS-induced production of PGE(2) in astrocyte cultures. In contrast, propofol had no effect on LPS-induced nitrite or TNF-alpha production in mixed glial cells. Conclusions The data demonstrate that ketamine inhibited some of the inflammatory responses of both astrocytes and microglial cells treated with LPS without causin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a large amount of evidence suggests a tight relationship between neuroinflammation and the pathogenesis of MDD. 485 – 487”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [487]
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Cytokines and acute neurodegeneration
Allan, S. M., & Rothwell, N. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094583 · Cited by 1,123
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01633.1998 · Cited by 713
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
GLIA: A novel drug discovery target for clinical pain
Watkins, L. R., & Maier, S. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1251 · Cited by 672
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“377 – 487 A summary of clinical trials related to new therapeutic drugs for MDD is shown in Table 1.”
BackgroundInflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289
Microglia in depression: current perspectives
Jia, X., Gao, Z., & Hu, H. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1815-6 · Cited by 282
“In addition, ketamine treatment sig- nificantly reduced LPS-induced production of TNF-α, NO and IL-1β in cultured microglia (Chang et al., 2009; Shibakawa et al., 2005).”
BackgroundThe cortical innate immune response increases local neuronal excitability leading to seizures
Rodgers, K. M., Hutchinson, M. R., Northcutt, A., Maier, S. F., Watkins, L. R., & Barth, D. S. (2009) · Brain · doi:10.1093/brain/awp177 · Cited by 162
“The purpose of this aneasthesia regime was to eliminate ketamine, which can influence epileptogenicity (Velisek et al., 1993; Borowicz and Czuczwar, 2003; Midzyanovskaya et al., 2004) and also attenuate LPS-induced inflammatory responses of glial cultures (Shibakawa et al., 2005).”
BackgroundNijs, J., Loggia, M. L., Polli, A., Moens, M., Huysmans, E., Goudman, L., Meeus, M., Vanderweeën, L., Ickmans, K., & Clauw, D. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1353603 · Cited by 141
“In vitro work showed that ketamine inhibited some of the inflammatory responses of both astrocytes and microglial cells [114].”
BackgroundAnderson, G., Berk, M., Dodd, S., Bechter, K., Altamura, A. C., Dell'Osso, B., Kanba, S., Monji, A., Fatemi, S. H., Buckley, P., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.008 · Cited by 140
In Vogue: Ketamine for Neuroprotection in Acute Neurologic Injury
Bell, J. D. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001856 · Cited by 131
The clinical role of NMDA receptor antagonists for the treatment of postoperative pain
Kock, M. F. D., & Lavand'homme, P. M. (2007) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2006.12.006 · Cited by 136
Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
Chang, Y., Lee, J.-J., Hsieh, C.-Y., Hsiao, G., Chou, D.-S., & Sheu, J.-R. (2009) · Mediators of Inflammation · doi:10.1155/2009/705379 · Cited by 108
“[17] also reported that ketamine (300∼ 1000 μM) significantly inhibited some of the inflammatory responses in microglial cells stimulated by LPS.”
BackgroundKetamine Use for Cancer and Chronic Pain Management
Culp, C. J., Kim, H. K., & Abdi, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.599721 · Cited by 117
“Ketamine may also play a role in decreasing neuronal inflammation by inhibiting cytokine release as ketamine reduces LPS-induced TNF-a production in mixed glial cell cultures (Shibakawa et al., 2005).”
BackgroundReview: the role of inflammation in depression.
Patel, A. J. (2013) · PubMed · Cited by 119
Perspectives on neuroinflammation and excitotoxicity: A neurotoxic conspiracy?
Viviani, B., Boraso, M., Marchetti, N., & Marinovich, M. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.03.004 · Cited by 114
Dexmedetomidine attenuates lipopolysaccharide-induced proinflammatory response in primary microglia
Peng, M., Wang, Y., Wang, C., & Chen, C. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.05.047 · Cited by 94
“[27] Shibakawa YS, Sasaki Y, Goshima Y, et al.”
BackgroundChao, C., Weng, C.-S., Chang, N., Lin, J.-S., Kao, S.-T., & Ho, F. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.10.011 · Cited by 88
“As to the effective LPS stimulation for obtaining distinct increases of nitrite in microglia, the range of LPS concentrations seemed variable [7,20,22,25] but might be higher (10 μg/mL rather than 1 μg/mL) [25] in comparison to those in macrophages [17-19].”
ResultImmune and Neuroprotective Effects of Physical Activity on the Brain in Depression
Phillips, C., & Fahimi, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00498 · Cited by 81
“Interestingly, the NMDA antagonist ketamine decreased lipopolysaccharide-induced TNF-α production in astrocyte and microglial cultures (Shibakawa et al., 2005).”
BackgroundGrosu, I., & Kock, M. D. (2011) · Anesthesiology Clinics · doi:10.1016/j.anclin.2011.04.001 · Cited by 93
Hollinger, A., Rüst, C. A., Riegger, H., Gysi, B., Tran, F., Brugger, J., Huber, J., Toft, K., Surbeck, M., Schmid, H.-R., et al. (2020) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2020.110099 · Cited by 80
Luo, T., Wu, J., Kabadi, S. V., Sabirzhanov, B. E., Guanciale, K., Hanscom, M., Faden, J., Cardiff, K., Bengson, C. J., & Faden, A. I. (2013) · Anesthesiology · doi:10.1097/aln.0000000000000020 · Cited by 78
General Anesthetics Inhibit LPS-Induced IL-1β Expression in Glial Cells
Tanaka, T., Kai, S., Matsuyama, T., Adachi, T., Fukuda, K., & Hirota, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082930 · Cited by 73
“Glial cells can produce cytokines, reactive oxygen radicals, and nitric oxide in response to infectious insults [23].”
BackgroundTargeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
Malar, D. S., Thitilertdecha, P., Ruckvongacheep, K. S., Brimson, S., Tencomnao, T., & Brimson, J. M. (2023) · CNS Drugs · doi:10.1007/s40263-023-01007-6 · Cited by 81
“Ketamine has been shown to prevent lipopolysaccharide (LPS)-induced TNF-α production in glial cells, astrocyte cultures and microglial cultures [324], suggesting that ketamine can prevent neuroinflammation.”
BackgroundNikkheslat, N. (2021) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2021.100383 · Cited by 71
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 79
“In vitro ketamine application to rodent glial cells [106] and macrophages [107] attenuated markers and mediators of LPS-induced inflammatory responses, such as TNF-α, IL1-β, high mobility group box 1 (HMGB1), nitric oxide (NO), inducible nitric oxide synthase (iNOS), and prostaglandin E-2.”
Pharmacology of Injectable Anesthetics, Sedatives, and Tranquilizers
Meyer, R. E., & Fish, R. E. (2008) · Elsevier eBooks · doi:10.1016/b978-012373898-1.50006-1 · Cited by 81
Dhote, F., Carpentier, P., Barbier, L., Peinnequin, A., Baille, V., Pernot, F., Testylier, G., Beaup, C., Foquin, A., & Dorandeu, F. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.12.024 · Cited by 61
Mei, X., Zhang, H., Wang, W., Wei, Y.-Y., Zhai, M., Wang, W., Xu, L., & Li, Y. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-6 · Cited by 54
“Interestingly, ketamine can inhibit lipopolysaccharide (LPS)-induced astrocyte activation [22], and can also decrease LPS-induced JNK phosphorylation (pJNK) to inhibit pro-inflammatory gene expression in macrophages [23].”
BackgroundInfluentialSong, S.-Y., Jung, Y. Y., Hwang, C. J., Lee, H. P., Sok, C. H., Kim, J. H., Lee, S., Seo, H. O., Hyun, B. K., Choi, D. Y., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-118 · Cited by 53
“Glial cells such as astrocytes and microglia can induce cytokines, reactive oxygen radicals (ROS), and nitric oxide (NO) which lead to exaggeration of the disease processes [14].”
BackgroundDrugs of anaesthesia and cancer
Santamaria, L. B., Schifilliti, D., Torre, D. L., & Fodale, V. (2009) · Surgical Oncology · doi:10.1016/j.suronc.2009.03.007 · Cited by 57
“have investigated the effects of this drug on the inflammatory responses of native glial cells highlighting how propofol does not affect the production of nitric oxide or tumour necrosis factor-alpha (TNF-alpha), which play key roles in acute and chronic neurodegenerative processes [34].”
BackgroundZhang, M., & Yin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1102312 · Cited by 65
Ketamine Inhibits Lipopolysaccharide-Induced Astrocytes Activation by Suppressing TLR4/NF-?B Pathway
Wu, Y., Li, W., Zhou, C., Lu, F., Gao, T., Liu, Y., Cao, J., Zhang, Y., Zhang, Y., & Zhou, C. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000341442 · Cited by 51
Gui, B., Su, M.-Y., Chen, J., Jin, L., Wan, R., & Qian, Y. (2012) · Inflammation · doi:10.1007/s10753-012-9478-x · Cited by 51
“Doses of 30 and 300 μM propofol had no effect on the production of TNF-α from rat glial cells stimulated by LPS in vitro [30].”
BackgroundNitric oxide: Antidepressant mechanisms and inflammation
Ghasemi, M. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.04.004 · Cited by 54
Mei, X., Zhou, Y., Wang, W., Tang, J., Wang, W., Zhang, H., Xu, L., & Li, Y. (2011) · Neurosignals · doi:10.1159/000324293 · Cited by 47
Lee, Y.-J., Choi, D.-Y., Choi, I. S., Han, J.-Y., Jeong, H.-S., Han, S. B., Oh, K.-W., & Hong, J. T. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-132 · Cited by 48
“Glial cells, consisting of astrocytes and microglia, can produce cytokines, reactive oxygen radicals, NO, and PGs, which lead to exaggeration of the disease processes [16].”
BackgroundRéus, G. Z., Simões, L. R., Colpo, G. D., Scaini, G., Oses, J. P., Generoso, J. S., Prossin, A. R., Kaddurah‐Daouk, R., Quevedo, J., & Barichello, T. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.016 · Cited by 51
The toxic effect of ketamine on SH‐SY5Y neuroblastoma cell line and human neuron
Mak, Y. T., Lam, W. P., Lü, L., Wong, Y. W., & Yew, D. T. W. (2009) · Microscopy Research and Technique · doi:10.1002/jemt.20774 · Cited by 51
“From recent studies, ketamine could influence glial cells including microglia and astrocytes in response to inflammatory insults (Chang et al., 2009; Shibakawa et al., 2005).”
BackgroundPrice, J. B., Bronars, C., Erhardt, S., Cullen, K. R., Schwieler, L., Berk, M., Walder, K., McGee, S. L., Frye, M. A., & Tye, S. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.002 · Cited by 47
“For example, ketamine can induce rapid molecular and synaptic changes in the PFC by suppressing glial activation and inflammation (Shibakawa et al., 2005) while also upregulating brain-derived neurotrophic factor (BDNF) and mammalian target of rapamycin (mTOR); these targets are critical to…”
Something new about ketamine for pediatric anesthesia?
Lois, F., & De Kock, M. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3282f82bde · Cited by 47
Ketamine inhibits LPS‐mediated BV2 microglial inflammation via NMDA receptor blockage
Lu, Y., Ding, X., Wu, X., & Huang, S. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12508 · Cited by 45
Boettger, M. K., Weber, K., Gajda, M. R., Bräuer, R., & Schaible, H. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.12.002 · Cited by 52
“Another putative mechanism via which ketamine and morphine might be capable of attenuating peripheral inflammation is a suppression of glia activation, which has been shown for both substances (Chao et al., 1997; Shibakawa et al., 2005).”
BackgroundThe Effect of Ketamine Anesthesia on the Immune Function of Mice with Postoperative Septicemia
Takahashi, T., Kinoshita, M., Shono, S., Habu, Y., Ogura, T., Seki, S., & Kazama, T. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181ed12fc · Cited by 44
The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease
Mohammad Shehata, I., Masood, W., Nemr, N., Anderson, A., Bhusal, K., Edinoff, A. N., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2022) · Neurology International · doi:10.3390/neurolint14020025 · Cited by 41
Tajerian, M., Leu, D., Yang, P., Huang, T., Kingery, W. S., & Clark, J. D. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000889 · Cited by 42
Effects of propofol on macrophage activation and function in diseases
Yi, S., Tao, X., Wang, Y., Cao, Q., Zhou, Z., & Wang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.964771 · Cited by 49
“However, propofol does not affect LPS-induced NO and TNF-α in mixed glial cells (Shibakawa et al., 2005), which suggests that the effect of propofol on inflammation may be related to the differentiation and expression pattern of macrophages.”
BackgroundNitric Oxide: Involvement in the Effects of Anesthetic Agents
Toda, N., Toda, H., Hatano, Y., & Warltier, D. C. (2007) · Anesthesiology · doi:10.1097/01.anes.0000287213.98020.b6 · Cited by 43
“Ketamine reduced lipopolysaccharide-induced tumor necrosis factor- production without inhibition of nitrite release in mixed rat glial cells, astrocyte cultures, and microglial cultures, whereas propofol had no effect on lipopolysaccharide-induced nitrite or tumor necrosis factor- production.(217) Ketamine, but not pr…”
BackgroundGuindon, J., LoVerme, J., Piomelli, D., & Beaulieu, P. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000263278.05423.a3 · Cited by 40
“Although, the action of propofol on neuronal cells is well documented, its involvement in glial cells seems controversial, since it had no effect on the production of nitric oxide or tumor necrosis factor- from glial cells stimulated by lipopolysaccharide (36).”
BackgroundPathologic role of nitrergic neurotransmission in mood disorders
Ghasemi, M., Claunch, J. D., & Niu, K. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.002 · Cited by 38
Mei, B., Xu, G., Han, W., Lu, X., Liu, R., Cheng, X., Chen, S., Gu, E., Liu, X., & Zhang, Y. (2019) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000779 · Cited by 38
Peters, A. J., Villasana, L., & Schnell, E. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002197 · Cited by 38
Yamaguchi, K., Kumakura, S., Murakami, T., Someya, A., Inada, E., & Nagaoka, I. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2875 · Cited by 34
“The glial cells of the CNS are involved in regulating the immune response under conditions of neuropathic pain (35) and ketamine has been shown to reduce the LPS-induced production of TNF-α and prostaglandin E2 by astrocytes (36).”
Inhibiting astrocytic activation: a novel analgesic mechanism of ketamine at the spinal level?
Mei, X., Wang, W., Wang, W., Li, Y., Zhang, H., Wu, S., Li, Y.-Q., & Xu, L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06087.x · Cited by 35
Ketamine – A New Antidepressant Drug with Anti-Inflammatory Properties
Jóźwiak-Bębenista, M., Sokołowska, P., Wiktorowska‐Owczarek, A., Kowalczyk, E., & Sienkiewicz, M. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001823 · Cited by 39
Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
Mhillaj, E., Morgese, M. G., & Trabace, L. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150105122422 · Cited by 32
Nonanesthetic Effects of Ketamine: A Review Article
Eldufani, J., Nekoui, A., & Blaise, G. A. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.04.029 · Cited by 34
“This, in turn, might lead to enhance blood-brain barrier permeability, a process that allows inflammatory cells, such as monocytes, neutrophils, and lymphocytes to cross the blood-brain barrier into the central nervous system [74,76,77].”
Peng, M., Ye, J., Wang, Y., Chen, C., & Wang, C. (2014) · Inflammation Research · doi:10.1007/s00011-014-0713-9 · Cited by 32
“[19] found that pretreatment with propofol had no effect on LPS-induced NO or TNF-a production in mixed glial cells at either the clinically relevant concentration (30 lM) or a concentration 10 times greater (300 lM).”
Yuhas, Y., Ashkenazi, S., Berent, E., & Weizman, A. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.012 · Cited by 30
“…LPS-induced production of TNFα, IL1β, and IL-6 in rat astrocytes (Wu et al., 2012); the production of nitric oxide and IL-1β- but not TNFα production in primary cultured rat microglial cells (Chang et al., 2009), and LPS-induced production of TNFα in rat mixed glial cells (Shibakawa et al., 2005).”
BackgroundResultInfluentialLee, J. W., Lee, M. S., Kim, T. H., Lee, H. J., Hong, S. S., Noh, Y. H., Hwang, B. Y., Ro, J. S., & Hong, J. T. (2007) · Mediators of Inflammation · doi:10.1155/2007/93148 · Cited by 28
Zhou, C., Zhu, Y., Zhao, P., Xu, C., Zhang, M.-X., Huang, H., Li, J., Liu, L., & Wu, Y. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000645 · Cited by 25
VanderZwaag, J., Halvorson, T., Dolhan, K., Šimončičová, E., Ben‐Azu, B., & Tremblay, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03772-0 · Cited by 30
Ketamine, benzoate, and sarcosine for treating depression
Cheng, Y., Lin, C., & Lane, H. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109351 · Cited by 21
Ki, K. H., Park, D., Lee, S. H., Kim, N. Y., Choi, B., & Noh, G. J. (2010) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2010.59.6.403 · Cited by 24
“Cultures were prepared from the whole brains of 2-day-old Sprague Dawley rats using the procedures described in previous studies [15,16].”
MethodKetamine attenuates the lipopolysaccharide-induced inflammatory response in cultured N2a cells
Yang, C., Jiang, R., Shen, J., Hong, T., Liu, N., Ding, L., Wang, D., Chen, L., Xu, B., & Zhu, B. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1465 · Cited by 18
Chang, Y., Li, J.-Y., Jayakumar, T., Hung, S.-H., Lee, W.-C., Manubolu, M., Sheu, J., & Hsu, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122545 · Cited by 16
“reported that ketamine at 100, 300, or 1000 μM significantly inhibited some of the inflammatory responses in microglial cells stimulated by lipopolysaccharide (LPS) without inducing cytotoxicity [39].”
BackgroundMedical management of acute pain in patients with chronic pain
Pinto, M. D., & Cahana, A. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.123 · Cited by 16
General anesthetic agents induce neurotoxicity through astrocytes
Yang, Y., Liu, T., Li, J., Yan, D., Hu, Y., Wu, P., Fang, F., McQuillan, P. M., Hang, W., Leng, J., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385857 · Cited by 16
“Paradoxically, propofol (30 and 300 μM) did not affect LPS-induced nitrite or TNF-α production in primary cultures of rat glial cells (Shibakawa et al., 2005).”
BackgroundKétamine en anesthésie pédiatrique : utile, futile ou … ?
Kock, M. D. (2007) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2007.04.009 · Cited by 15
Effects of erythropoietin on intracellular calcium concentration of rat primary cortical neurons
Andoh, T., Echigo, N., Kamiya, Y., Hayashi, M., Kudoh, I., & Goto, T. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.077 · Cited by 14
Self-citationSynergistic activation of lipopolysaccharide-stimulated glial cells by propofol
Ko, H. M., Kim, S. Y., Joo, S. H., Cheong, J. H., Yang, S., Shin, C. Y., & Koo, B. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.089 · Cited by 12
Liu, J., Gao, X.-F., Ni, W., & Li, J. (2011) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0139-4 · Cited by 14
“It has been reported that 30–300 lM propofol did not influence LPS-induced TNF-a production in mixed glial cells [33].”
BackgroundIntravitreal ketamine promotes neuroprotection in rat eyes after experimental ischemia
Dourado, L. F. N., Oliveira, L. G., da Silva, C. N., Toledo, C. R., Fialho, S. L., Jorge, R., & Silva‐Cunha, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110948 · Cited by 11
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
Kositsyn, Y. M., de Abreu, M. S., Kolesnikova, T. O., Lagunin, A. A., Poroikov, V., Harutyunyan, H. S., Yenkoyan, K. B., & Kalueff, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119482 · Cited by 12
“Likewise, ketamine lowers lipopolysaccharide (LPS)-induced proinflammatory cytokines interleukin (IL) IL-1β and tumor necrosis factor (TNF)-α in microglia [60].”
BackgroundMușat, M. I., Ifrim-Predoi, A.-M., Mitran, S. I., Osiac, E., & Cătălin, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083558 · Cited by 9
“The ability to reduce astrocytic activation could contribute to ketamine’s rapid and sustained antidepressant effects, particularly in conditions characterized by heightened neuroinflammatory states [79,80].”
Lamontagne, S. J., Ballard, E. D., & Zarate, C. A. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100450 · Cited by 12
“inhibit astrocytic activation (Shibakawa et al., 2005)—a mechanism that likely underlies its analgesic properties (Mei et al.”
BackgroundPreventive effects of propofol and ketamine on renal injury in unilateral ureteral obstruction
Dikmen, B., Yağmurdur, H., Akgül, T., Astarcı, M., Üstün, H., & Germíyanoğlu, C. (2010) · Journal of Anesthesia · doi:10.1007/s00540-009-0861-1 · Cited by 8
“not reduced iNOS-mediated NO production after complete UO is inconsistent with earlier studies reporting inhibitory effects of ketamine on the iNOS-mediated NO release from alveolar macrophages in response to lipopolysaccharide in vitro [39, 40].”
ResultBarone, A., Vellucci, L., Ciccarelli, M., Matrone, M., Simone, G. D., Iannotta, F., Iasevoli, F., & de Bartolomeis, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178598 · Cited by 9
“In preclinical models, clozapine enhances dendritic spine formation and shows antioxidant and anti-apoptotic properties in neural stem cells exposed to glutamatergic stressors such as NMDAR antagonists [230,231].”
Qi, A., Cao, Y., & Ai-zhong, W. (2020) · BioMed Research International · doi:10.1155/2020/8868839 · Cited by 6
RetractedYağmurdur, H., Binnetoğlu, K., Astarcı, H. M., & Yağmurdur, M. C. (2017) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020170050000009 · Cited by 5
Effects of different anesthetic agents on GM-CSF, MCP1, IL1α and TNFα levels in rat sepsis model
Vojvodić, D., Miljanović, O., Djurdjević, D., Gataric, S., Stanojević, I., Obradović, D., Šurbatović, M., & Andrić, J. F. (2013) · Acta veterinaria · doi:10.2298/avb1303125v · Cited by 4
Herpes viruses and neuroinflammation
Doorduin, J. (2010) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 4
A study about the synthesis of seven-membered-ring analogues of ketamine
Moghimi, A., Shahdadi, M. R., Keshipour, S., & Sadeghzadeh, M. (2014) · Research on Chemical Intermediates · doi:10.1007/s11164-014-1790-7 · Cited by 3
Fraites, M. J. P., & Wood, C. E. (2011) · Reproductive Sciences · doi:10.1177/1933719111398499 · Cited by 2
“Ketamine also reduced LPSinduced PGE2 production in primary glial cell cultures not thought to express NMDA receptors.(39) In the present study, cellular hypoxia caused by BCO may have stimulated transcription factors such as NF-kB; therefore, we cannot rule out the possibility that ketamine interactions with these fa…”
BackgroundKim, G. M., Lee, C., & Jang, T. C. (2021) · Toxicology Research · doi:10.1093/toxres/tfab115 · Cited by 3
Effects of ketamine on pro-inflammatory mediators in equine models
Lankveld, D. P. K. (2007) · Utrecht University Repository (Utrecht University) · Cited by 2
Иванова, Е. А., Matyushkin, A., Sorokina, A., Alexeeva, S., Сергеевич, К. К., Мирошкина, И. А., Voronina, T., & Дурнев, А. Д. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2024.002 · Cited by 1
Comparison of Ketamine to Haloperidol for Preventing Delirium in ICU Elderly Patients
Hosseindoost, S., Zabetpoor, M. J., Ghazi, S. F., Orandi, A., & Pestei, K. (2023) · Archives of Neuroscience · doi:10.5812/ans-140241 · Cited by 1
Abbas, H., Ansari, A. J., Arshad, Z., Mahdi, A. A., & Bogra, J. (2013) · The Internet Journal of Anesthesiology · Cited by 1
Rossin, P. R. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.22.2013.tde-08012014-153310
Pharmacology of Novel Non-NSAID Analgesics
Lavand'homme, P. M., & Kock, M. F. D. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576706.009
Wood, L. (2011) · Library and Archives Canada (Government of Canada) · Cited by 1
Hassani, M., Sabouni, F., Ansari, M., Emamgholipour, S., Fallah, M., Abbasi, S., & Majd, S. A. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8027 · Cited by 1
“Isolated cells were cultured according to previous studies with some modifications (3,12-14).”
Anesthesia and Cancer Recurrence
Goneppanavar, U., & Kaur, J. (2021) · Springer eBooks · doi:10.1007/978-981-16-0006-7_3
Kalra, H., Dean, O. M., Dodd, S., & Berk, M. (2012) · doi:10.2217/ebo.11.273
Krishnan, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223828124010008
Huang, L., Tüzer, F., Murtha, A., Green, M. S., Torres, C. A., Liu, H., & Malaeb, S. (2024) · Anesthesiology Research and Practice · doi:10.1155/2024/8876548
Understanding pharmaceutical agents used in neuroanesthesia
Looney, K., Fiorda‐Diaz, J., Stoicea, N., Bergese, S. D., & Brophy, G. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22273-3.00006-7
Physiopathologie et modulation de l’activation microgliale secondaire au sepsis
Verdonk, F. (2016) · theses.fr (ABES) · doi:10.70675/8d3a9e0ez15f7z446bzb0e4z56e24e61058a
Sedation as an Immunomodulator of Inflammatory Responses in the Lung–Brain Axis of ARDS
Gălbenușe, C.-G., Stănculescu, A. D., & Drăgoescu, A. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114700
Metadata
- Authors
- Shibakawa, Y. S., Sasaki, Y., Goshima, Y., Echigo, N., Kamiya, Y., Kurahashi, K., Yamada, Y., & Andoh, T.
- Affiliations
- Yokohama City University (JP)
- Corresponding author
- Andoh, T.
- Venue
- British Journal of Anaesthesia
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 95
- Issue
- 6
- Pages
- 803-810
- ISSN
- 0007-0912 (ISSN-L)
- OpenAlex
- W2122830024
- Cited by
- 96
- References
- 38
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 8 · 2012: 7
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4386 d)
- Locations
- British Journal of Anaesthesia (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Fonden til Lægevidenskabens Fremme
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- ketamine, propofol, glial cells, lipopolysaccharide, neuroinflammation, astrocytes, microglia, nitric oxide, TNF-α, prostaglandin E2, anti-inflammatory activity
- MeSH terms
- Anesthetics, Dissociative, Animals, Astrocytes, Cells, Cultured, Dose-Response Relationship, Drug, Ketamine, Lipopolysaccharides, Neuroglia, Nitric Oxide, Tumor Necrosis Factor-alpha, Dinoprostone, Propofol, Rats, Wistar, Microglia, Anesthetics, Intravenous, Inflammation Mediators, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.